Pages that link to "Q68801560"
Jump to navigation
Jump to search
The following pages link to Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass (Q68801560):
Displaying 50 items.
- Bone mass in patients with rheumatoid arthritis (Q33564801) (← links)
- Management of corticosteroid-induced osteoporosis (Q33857195) (← links)
- Cortical bone loss in triamcinolone-treated mice (Q34044751) (← links)
- Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. (Q34290463) (← links)
- Corticosteroid-Induced osteoporosis: detection and management (Q34323719) (← links)
- Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease (Q34377588) (← links)
- A controlled study of bone mineral density in patients with inflammatory bowel disease (Q34408596) (← links)
- Osteoporosis in patients with inflammatory bowel disease (Q34527150) (← links)
- Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease (Q34531383) (← links)
- Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment (Q34571076) (← links)
- Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. (Q34761706) (← links)
- Endocrine complications in pediatric patients with acute lymphoblastic leukemia (Q34914210) (← links)
- Risk factors for osteoporosis and associated fractures (Q35055777) (← links)
- Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment (Q35601856) (← links)
- Bone mineral content in bronchopulmonary dysplasia (Q35604073) (← links)
- Growth hormone deficiency during puberty reduces adult bone mineral density (Q35628705) (← links)
- Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club (Q36283113) (← links)
- Bone mineral content after renal transplantation. Placebo-controlled prospective study with 1,25-dihydroxy vitamin D3. (Q36601372) (← links)
- Mineral loss in cortical and trabecular bone during high-dose prednisone treatment (Q36605167) (← links)
- Early injury to cortical and cancellous bone from induction chemotherapy for adolescents and young adults treated for acute lymphoblastic leukemia (Q36697564) (← links)
- Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content (Q36778199) (← links)
- Differential effects of endocrine dysfunction on the axial and the appendicular skeleton (Q36984174) (← links)
- Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration (Q37041053) (← links)
- Bone involvement in exogenous hypercortisolism (Q37161922) (← links)
- Locomotor side-effects of corticosteroids (Q37779554) (← links)
- Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients (Q38533585) (← links)
- Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations. (Q39177137) (← links)
- Disordered mineral metabolism produced by ketogenic diet therapy (Q39693081) (← links)
- Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration (Q40244147) (← links)
- Drug-induced disorders of vitamin D and mineral metabolism (Q40291073) (← links)
- Drug-Induced Metabolic Bone Disease (Q40472425) (← links)
- Bone complications of anticonvulsants (Q40612852) (← links)
- Effects of Diabetes Mellitus on Bone Mass in Juvenile and Adult-Onset Diabetes (Q41076132) (← links)
- Effect of calcitonin and vitamin D in osteoporosis (Q41262291) (← links)
- Bone densitometry using computed tomography. Part I: selective determination of trabecular bone density and other bone mineral parameters. Normal values in children and adults (Q41483990) (← links)
- Bone mass is related to creatinine clearance in normal elderly women (Q41818161) (← links)
- Increased blood cortisol in alcoholic patients with aseptic necrosis of the femoral head (Q42662764) (← links)
- Corticosteroid-induced osteoporosis in patients with uveitis (Q44113278) (← links)
- Trabecular Bone Morphometry in Beagles with Hyperadrenocorticism and Adrenal Adenomas (Q44194355) (← links)
- Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis (Q44482933) (← links)
- Osteoporosis in steroid-dependent asthma. (Q46018587) (← links)
- Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. (Q46036451) (← links)
- Reduced strength of rat cortical bone after glucocorticoid treatment (Q50144829) (← links)
- Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy (Q51647891) (← links)
- Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis. (Q54102758) (← links)
- Prophylactic Vitamin D Supplement to Epileptic Children on Anticonvulsant Drugs (Q66941133) (← links)
- Serum vitamin D and related mineral metabolism in cystic fibrosis (Q66947464) (← links)
- Hypercalcaemia in Chronic Lymphatic Leukaemia (Q67332055) (← links)
- Long-term therapy with cyclosporin A does not influence serum concentrations of vitamin D metabolites in patients with multiple sclerosis (Q67551282) (← links)
- Effect of Glucocorticoids on Bone Gla Protein Values -BGP as a Good Marker of Osteoporosis- (Q67846274) (← links)